Northwestern Mutual Wealth Management Co. boosted its position in shares of Encompass Health Corporation (NYSE:EHC – Free Report) by 3,059,159.7% in the fourth quarter, Holdings Channel reports. The fund owned 3,793,482 shares of the company’s stock after purchasing an additional 3,793,358 shares during the quarter. Northwestern Mutual Wealth Management Co.’s holdings in Encompass Health were worth $402,640,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently bought and sold shares of EHC. Millennium Management LLC increased its position in Encompass Health by 140.0% during the third quarter. Millennium Management LLC now owns 1,223,665 shares of the company’s stock valued at $155,430,000 after acquiring an additional 713,738 shares during the last quarter. 8 Knots Management LLC purchased a new stake in Encompass Health during the second quarter valued at $78,644,000. Alliancebernstein L.P. increased its position in Encompass Health by 23.4% during the third quarter. Alliancebernstein L.P. now owns 2,515,878 shares of the company’s stock valued at $319,567,000 after acquiring an additional 476,564 shares during the last quarter. Thrivent Financial for Lutherans increased its position in Encompass Health by 57.8% during the third quarter. Thrivent Financial for Lutherans now owns 1,194,859 shares of the company’s stock valued at $151,544,000 after acquiring an additional 437,464 shares during the last quarter. Finally, Raymond James Financial Inc. increased its position in Encompass Health by 34.8% during the third quarter. Raymond James Financial Inc. now owns 1,541,336 shares of the company’s stock valued at $195,780,000 after acquiring an additional 397,694 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.
Analysts Set New Price Targets
A number of analysts recently commented on the company. Barclays reduced their price objective on Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, May 5th. Wall Street Zen upgraded Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Two investment analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $144.17.
Encompass Health Stock Performance
Shares of EHC opened at $106.64 on Friday. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76. The business has a 50-day simple moving average of $102.94 and a two-hundred day simple moving average of $106.40. The stock has a market cap of $10.58 billion, a price-to-earnings ratio of 17.80, a PEG ratio of 2.34 and a beta of 0.72. Encompass Health Corporation has a 52 week low of $92.77 and a 52 week high of $127.99.
Encompass Health (NYSE:EHC – Get Free Report) last issued its quarterly earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, topping analysts’ consensus estimates of $1.51 by $0.09. The business had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The business’s quarterly revenue was up 9.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, analysts expect that Encompass Health Corporation will post 5.97 EPS for the current year.
Encompass Health Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 1st will be given a $0.19 dividend. The ex-dividend date is Wednesday, July 1st. This represents a $0.76 dividend on an annualized basis and a yield of 0.7%. Encompass Health’s dividend payout ratio is presently 12.69%.
Insider Transactions at Encompass Health
In other news, EVP Patrick William Tuer sold 682 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $104.56, for a total value of $71,309.92. Following the completion of the transaction, the executive vice president owned 24,755 shares of the company’s stock, valued at $2,588,382.80. This represents a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Treasurer Edmund Fay sold 11,937 shares of the company’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $107.00, for a total value of $1,277,259.00. Following the completion of the transaction, the treasurer directly owned 89,325 shares of the company’s stock, valued at approximately $9,557,775. This trade represents a 11.79% decrease in their position. The disclosure for this sale is available in the SEC filing. Corporate insiders own 1.80% of the company’s stock.
Encompass Health Company Profile
Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.
Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.
Read More
- Five stocks we like better than Encompass Health
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
